- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| OWLET Aktie jetzt für 0€ handeln | |||||
| 14.08. | Owlet: Hauptversammlung stimmt für Vergütungsplan und wählt Direktoren | 1 | Investing.com Deutsch | ||
| 14.08. | Owlet, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 12.08. | Owlet reaffirms $118M-$122M 2026 revenue outlook while raising adjusted EBITDA to $10.75M-$12.75M | 1 | Seeking Alpha | ||
| 11.08. | Owlet Q2 2026 slides: record revenue, subscription surge drive rally | 1 | Investing.com | ||
| 11.08. | Earnings Call: Owlet übertrifft Q2-Prognosen 2026, Aktie legt nachbörslich zu | 1 | Investing.com Deutsch | ||
| 11.08. | Owlet GAAP EPS of -$0.01 beats by $0.08, revenue of $33.9M beats by $2.18M | 1 | Seeking Alpha | ||
| 11.08. | Owlet, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.07. | Owlet Announces New $25 Million Credit Facility With Wells Fargo | 3 | pulse2.com | ||
| 01.07. | Owlet, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 19.06. | Owlet (OWLT) Moves 7.3% Higher: Will This Strength Last? | 2 | Zacks | ||
| 05.06. | Owlet, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.05. | Here's Why Owlet (OWLT) Crashed 60% in Q1 | 7 | Insider Monkey | ||
| 11.05. | Owlet, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 11.05. | Owlet, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.05. | Owlet, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.04. | Owlet, Inc. - 10-K/A, Annual Report | - | SEC Filings | ||
| 06.04. | Führungswechsel bei Owlet: CEO Jonathan Harris tritt zurück, Gründer Kurt Workman übernimmt | 2 | Investing.com Deutsch | ||
| 06.04. | Owlet CEO Jonathan Harris resigns, founder Kurt Workman returns | 1 | Investing.com | ||
| 06.04. | Owlet, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.03. | Owlet, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings |
1 2 Weiter >>
40 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BICO GROUP | 1,880 | -0,42 % | BICO-Preisnews: Anstieg um 10,09% innerhalb von 60 Minuten | ||
| MCKESSON | 773,20 | +0,23 % | McKesson To Acquire Precision Medicine Group For $2.25 Bln | WASHINGTON (dpa-AFX) - Tuesday, McKesson Corp. (MCK) announced an agreement to acquire Precision Medicine Group, LLC, a global provider of clinical research and biopharma commercialization services... ► Artikel lesen | |
| ORGANON | 11,840 | -0,34 % | Dividendenbekanntmachungen (14.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADM HAMBURG AG DE0007269003 - 13,58 EUR AGCO CORPORATION US0010841023 0,3 USD 0,2602 EUR AGNT INC US30212W1009 0,05 USD 0,0433... ► Artikel lesen | |
| QUIDELORTHO | 12,645 | 0,00 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| NANO-X IMAGING | 0,832 | +0,23 % | Nano-X Imaging Ltd: Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026 | ||
| PERSPECTIVE THERAPEUTICS | 2,726 | +2,02 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2026 Results | Advancing VMT-a-NET toward a Phase 3 study in neuroendocrine tumors, subject to regulatory alignment: regulatory engagement ongoing; clinical site activation targeted around year-end 2026 subject... ► Artikel lesen | |
| ROCKWELL MEDICAL | 8,170 | 0,00 % | XFRA RWM: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILROCKWELL MEDICAL... ► Artikel lesen | |
| NUWELLIS, INC | 0,870 | -2,12 % | Nuwellis, Inc. - 8-K, Current Report | ||
| HAEMONETICS | 90,00 | 0,00 % | Biotech Stocks At 52-Week Highs - Scribe Therapeutics Continues Rise After Nasdaq Debut, Royalty Pharma, Haemonetics, 10x Genomics, Labcorp Holdings | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 20, 2026, driven by key catalysts such as new product launches and the prospective release of data from clinical... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,850 | +0,10 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| NEURONETICS | 2,610 | +3,16 % | Neuronetics Reports Second Quarter 2026 Financial and Operating Results | MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics"), a leader in interventional mental health that combines its NeuroStar® TMS technology... ► Artikel lesen | |
| CONCENTRA GROUP | 34,250 | 0,00 % | S&P stuft Concentra auf BB hoch - Geringere Verschuldung als Treiber | ||
| OPTIMIZERX | 7,950 | 0,00 % | OptimizeRx Corporation: OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth | The Company Names Andy D'Silva as the next Chief Financial Officer and Heather Favazza as Chief Accounting Officer effective January 1, 2027 Planned Transition Reflects Strong Succession Planning... ► Artikel lesen | |
| PULMONX | 2,140 | +3,88 % | Pulmonx Corporation: Pulmonx Reports Second Quarter 2026 Financial Results | REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| ORTHOFIX MEDICAL | 8,000 | -1,23 % | Orthofix Medical Inc. - S-8, Securities to be offered to employees in employee benefit plans |
OWLET INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 4,965 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OWLET INC finden Sie auf Wallstreet Online.